83 related articles for article (PubMed ID: 2131211)
1. Omeprazole: blocks gastric acid secretion completely.
Drug Ther Bull; 1990 Jun; 28(13):49-52. PubMed ID: 2131211
[No Abstract] [Full Text] [Related]
2. [Omeprazole. A new substance for inhibiting acid production].
Uhl D
Med Monatsschr Pharm; 1990 Feb; 13(2):34-7. PubMed ID: 2179691
[No Abstract] [Full Text] [Related]
3. [Omeprazole].
Isal JP
Gastroenterol Clin Biol; 1987 Nov; 11(11):768-80. PubMed ID: 3322924
[No Abstract] [Full Text] [Related]
4. [Treatment of peptic ulcer and reflux esophagitis with enzyme inhibitors].
Moriya S; Omura N; Kashiwagi H; Inagaki Y; Aoki T
Nihon Rinsho; 1991 Sep; 49(9):2115-9. PubMed ID: 1835742
[No Abstract] [Full Text] [Related]
5. Controversies, dilemmas, and dialogues. Reduction of gastric acidity in the treatment of peptic ulcer disease: how low should we go?
Peterson WL; Harford WV
Am J Gastroenterol; 1991 Jun; 86(6):671-5. PubMed ID: 1674838
[No Abstract] [Full Text] [Related]
6. Omeprazole: a new approach to gastric acid suppression.
Buhl K; Clearfield HR
Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
[TBL] [Abstract][Full Text] [Related]
7. [Omeprazole. A new inhibitor of gastric secretion].
Farup PG
Tidsskr Nor Laegeforen; 1989 Aug; 109(22):2156-7. PubMed ID: 2772881
[No Abstract] [Full Text] [Related]
8. Clinical utility and safety of omeprazole.
Walan A
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():107-11. PubMed ID: 2657279
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole in the treatment of peptic ulcers and gastroesophageal reflux disease.
Cappell MS
N J Med; 1992 Oct; 89(10):762-4. PubMed ID: 1461581
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole: a comprehensive review.
Massoomi F; Savage J; Destache CJ
Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
[TBL] [Abstract][Full Text] [Related]
11. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
Bulgakov SA
Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266
[No Abstract] [Full Text] [Related]
12. [Omeprazole. An effective antisecretory agent in ulcerative disease and reflux esophagitis].
Lauritsen K; Laursen LS; Madsen JR
Ugeskr Laeger; 1989 Jul; 151(28):1831-3. PubMed ID: 2773093
[No Abstract] [Full Text] [Related]
13. [Omeprazole in peptic ulcer--pros and cons].
Stasiewicz J
Wiad Lek; 1986 Jun; 39(11):765-71. PubMed ID: 3535259
[No Abstract] [Full Text] [Related]
14. [Reduced ex vivo production of superoxide anion by polymorphonuclear leukocytes during therapy with omeprazole. A pharmacological effect?].
Capodicasa E; Ciaccio V; Corazzi F; De Bellis F; Bucaneve G; Ficola F; Pelli MA
Minerva Gastroenterol Dietol; 1994 Sep; 40(3):105-11. PubMed ID: 7948319
[TBL] [Abstract][Full Text] [Related]
15. [Advances in the knowledge of peptic-acid dependent diseases].
Mazure PA; Pigliacampo J
Acta Gastroenterol Latinoam; 1989; 19(3):165-73. PubMed ID: 2576850
[No Abstract] [Full Text] [Related]
16. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical efficacy and problems; gastric mucosa proton pump inhibitors].
Okabe S; Akimoto Y
Nihon Rinsho; 1988 Jan; 46(1):33-8. PubMed ID: 2836641
[No Abstract] [Full Text] [Related]
17. [Reply to the critique by Drs. Díaz de Rojas y Castelló Tapias].
Cataldi R; Meeroff M
Rev Esp Enferm Dig; 1991 Oct; 80(4):285-6. PubMed ID: 1805899
[No Abstract] [Full Text] [Related]
18. [Omeprazole in the therapy of acid-induced diseases].
Simon B; Dammann HG; Müller P
Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
[TBL] [Abstract][Full Text] [Related]
19. Omeprazole and reflux oesophagitis.
Kerr GD
Aliment Pharmacol Ther; 1994 Apr; 8(2):263. PubMed ID: 8038359
[No Abstract] [Full Text] [Related]
20. Clinical experience with omeprazole: assessment of efficacy and safety.
Walan A
J Gastroenterol Hepatol; 1989; 4 Suppl 2():27-33. PubMed ID: 2491359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]